Huge dermoid cyst of the spleen

University of Zagreb, Zagrabia, Grad Zagreb, Croatia
The Indian Journal of Pediatrics (Impact Factor: 0.87). 02/2010; 77(4):454-5. DOI: 10.1007/s12098-010-0025-1
Source: PubMed


Primary splenic cysts are uncommon lesions of the spleen. Splenic cysts are classified as primary or secondary on the basis of presence or absence of an epithelial lining. The primary cysts are further subdivided as parasitic or non-parasitic. The congenital non-parasitic cysts are rarely met in clinical practice and it constitutes approximately 10% of all splenic cysts. Congenital cysts are true cysts with an epithelial. Secondary cysts are in most cases posttraumatic. Patient at admission had lower abdominal pain and splenic cyst was asymptomatic. In routine abdominal pain investigation we found cyst of the spleen in diameter 2 cm. We made serodiagnostic tests for echinococcosis which were negative. After 3 years she came with left upper quadrant enlargement with tangible abdominal mass, increasing abdominal girth, decrease of appetite and sometimes vomiting. CT scan showed cyst enlargement in diameter 8 x 6 cm. Operative treatment was necessary and splenectomy was done. However, splenectomy remains a relatively safe procedure, associated with few complications and avoiding any future problems.

84 Reads
  • [Show abstract] [Hide abstract]
    ABSTRACT: Epidermoid cysts of the spleen are a rare lesion comprising less than 10% benign non-parasitic splenic cysts. Two boys and three girls, aged 13 to 24 years (mean 18.0 years) were diagnosed over a 4-year period. Presenting symptoms were dull, acute left hypochondrium pain and diffuse abdominal pain. Hemogram and routine analyses, as well as radiography were performed for the diagnosis. Ultrasound and CT confirmed the cystic nature of the lesion. Definitive diagnosis is made by pathological findings. Was performed splenectomy on one patient, and was performed a partial splenectomy on the other patients, in order to eliminate the symptoms produced by the cyst and prevent potential complications (postspleenectomiam sepsis). Patients were examined postoperatively. They were asymptomatic and with a normal spleen remnant detected by ultrasound and CT. Routine hematological data, blood clotting factors, and immunoglobulins were normal.
    Acta chirurgica iugoslavica 02/2008; 55(1):63-7.
  • [Show abstract] [Hide abstract]
    ABSTRACT: Nonparasitic splenic cysts (NPSCs) are uncommon in children. The aim of this multinational and multicentric study was to present the authors' experience as well as the changing trends in the management of NPSCs over the last 25 years. From 1981 to 2005, 50 children or adolescents were surgically treated for NPSCs in 6 paediatric surgical centres in four European countries. The medical records of these 50 patients with NPSCs were reviewed retrospectively. Twenty-six male and 24 female patients were operated on. Age at surgery ranged from 1 to 17 years (mean 11.9). Seventeen patients were symptomatic. Six total (4 open and 2 laparoscopic) and 26 partial (22 open and 4 laparoscopic) splenectomies were performed. Laparoscopic fenestration or deroofing and open cystectomy was carried out in 9 patients, respectively. Histological findings revealed the lesion to be an epidermoid cyst (n = 28), a pseudocyst (n = 15) or a mesothelial cyst (n = 2). In 5 patients haemangioma or lymphangioma was the pathological diagnosis. At a mean follow-up of 2.9 years, residual cysts were found in 8 laparoscopically treated patients, 4 of whom required re-do laparoscopy or open surgery. Over the last two decades, the surgical treatment of NPSCs has changed from a formerly customary total splenectomy to spleen-conserving procedures, such as total cystectomy with or without partial splenectomy or partial cystectomy. These therapeutic modalities can be performed laparoscopically, if technically possible. Fenestration or deroofing of the cyst resulted in a high recurrence rate (7/9).
    European Journal of Pediatric Surgery 01/2007; 16(6):415-9. DOI:10.1055/s-2006-924748 · 0.99 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: This brief note addresses the historical background of the invention of the enzyme immunoassay (EIA) and enzyme-linked immunosorbent assay (ELISA). These assays were developed independently and simultaneously by the research group of Peter Perlmann and Eva Engvall at Stockholm University in Sweden and by the research group of Anton Schuurs and Bauke van Weemen in The Netherlands. Today, fully automated instruments in medical laboratories around the world use the immunoassay principle with an enzyme as the reporter label for routine measurements of innumerable analytes in patient samples. The impact of EIA/ELISA is reflected in the overwhelmingly large number of times it has appeared as a keyword in the literature since the 1970s. Clinicians and their patients, medical laboratories, in vitro diagnostics manufacturers, and worldwide healthcare systems owe much to these four inventors.
    Clinical Chemistry 01/2006; 51(12):2415-8. DOI:10.1373/clinchem.2005.051532 · 7.91 Impact Factor
Show more


84 Reads
Available from